Indo Us Bio-Tech Fair Value
Indo Us Bio-Tech (INDOUS) average fair value is ₹78.65 across 2 valuation models — P/B Based Valuation, Asset-Based Valuation, vs a current market price of ₹100.58 (-21.8%), fair value range ₹43.33–₹113.97. For live price and a broader fundamental view, visit Indo Us Bio-Tech share price today.
Fair Value Analysis Export
INDOUS Fair Value vs Current Price — Valuation Summary
INDOUS average fair value, fair value range, price gap and valuation status across 2 models: P/B Based Valuation, Asset-Based Valuation. Also explore Indo Us Bio-Tech stock price data download to track price trends across different timeframes.
P/B Based Valuation
Asset-Based Valuation
INDOUS Fair Value Analysis — Data Sources & Coverage
Indo Us Bio-Tech financial data sources, valuation methods applied and sector benchmarks used. See INDOUS price to book ratio to compare market price against book value per share.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
INDOUS vs FMCG Sector Peers — P/E, P/B & Market Cap
Indo Us Bio-Tech P/E ratio, P/B ratio and market capitalisation vs FMCG sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Sarda Proteins | SRDAPRT | -223.5 | 0.85 | ₹76 |
| Swasth Foodtech | SWASTH | 4.48 | 0.48 | ₹10 |
| Shreeji Global FMCG | SHETHJI | - | 3.18 | ₹372 |
| RKD Agri & Retail | RKDAGRRTL | -77.11 | 9.34 | ₹41 |
| Kwality Walls | KWIL | -20.89 | 9.2 | ₹6,210 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.